USANA CSO granted 24,526 restricted stock units

Armstrong Kathryn Michelle reported acquisition or exercise transactions in this Form 4 filing.

Accepted by SEC EDGAR 02/23/2026 - 07:03 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Armstrong Kathryn Michelle reported acquisition or exercise transactions in this Form 4 filing.

USANA Health Sciences chief scientific officer Kathryn Michelle Armstrong received a grant of 24,526 restricted stock units on February 19, 2026. Each unit represents a contingent right to receive one share of USANA common stock. After this grant, she beneficially owns 44,782 restricted stock units directly. The units vest in four equal 25% installments on each February 19 following the grant date.

Insider Trade Summary

Grant/Award: 24,526 shares

Grant/Award 1 txn

Insider Armstrong Kathryn Michelle

Role CHIEF SCIENTIFIC OFFICER

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	24,526	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 44,782 contracts (Direct)

Holdings Before and After: Restricted Stock Units, 20,256 to 44,782 contracts (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
2. F2. On February 19th 2026, the reporting person was granted restricted stock units, vesting at 25% on each 19th of February thereafter.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did USANA (USNA) disclose about Kathryn Armstrong in this Form 4?

USANA reported that chief scientific officer Kathryn Michelle Armstrong received 24,526 restricted stock units on February 19, 2026. These equity awards increase her direct beneficial ownership to 44,782 restricted stock units tied to USANA common shares, aligning a portion of her compensation with shareholder interests.

How many restricted stock units did USANA’s chief scientific officer receive?

Kathryn Michelle Armstrong received a grant of 24,526 restricted stock units. Each unit represents a contingent right to one share of USANA Health Sciences common stock, providing equity-based compensation that will vest over time according to the schedule disclosed in the filing footnotes.

What is the vesting schedule for Kathryn Armstrong’s 2026 USNA RSU grant?

The restricted stock units granted on February 19, 2026 vest in four equal installments. Twenty-five percent of the 24,526 units vest on each February 19 after the grant date, creating a multi-year vesting period that encourages longer-term retention and performance alignment for the chief scientific officer.

What does each USNA restricted stock unit granted to Kathryn Armstrong represent?

Each restricted stock unit granted to Kathryn Armstrong represents a contingent right to receive one share of USANA common stock. Actual share delivery depends on meeting the vesting conditions over time, as outlined in the footnotes describing the annual 25% vesting on future February 19 dates.

How many USANA restricted stock units does Kathryn Armstrong own after this transaction?

Following the February 19, 2026 grant, Kathryn Michelle Armstrong directly beneficially owns 44,782 restricted stock units. This total reflects the newly awarded 24,526 units plus previously held awards, all representing potential future USANA common shares subject to their individual vesting terms and conditions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Armstrong Kathryn Michelle

(Last) (First) (Middle)

3838 PARKWAY BLVD.

(Street)

SALT LAKE CITY UT 84120

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF SCIENTIFIC OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	02/19/2026		A		24,526		(2)	(2)	Common Stock	24,526	$0	44,782	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.

2. On February 19th 2026, the reporting person was granted restricted stock units, vesting at 25% on each 19th of February thereafter.

Remarks:

	/s/ Joshua Foukas, Attorney-in-Fact	02/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.